The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$5.20

Today's change0.00 0.00%
Updated at previous session's close. Delayed by at least 15 minutes.
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$5.20

Today's change0.00 0.00%
Updated at previous session's close. Delayed by at least 15 minutes.

Nuvo Pharmaceuticals Inc closed at $5.20.

Over the last five days, shares have lost 1.70% and sit 1.17% above their 52-week low. This security has underperformed the S&P TSX by 24.99% during the last year.

Key company metrics

  • Trailing P/E8.27×
  • P/E 1 year forward7.03×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.63
Updated at previous session's close. Delayed by at least 15 minutes.
S&P TSX0.91%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue6688
Total other revenue--------
Total revenue6688
Gross profit3355
Total cost of revenue3333
Total operating expense4465
Selling / general / administrative1122
Research & development1000
Depreciation / amortization0000
Interest expense (income), net operating--00--
Unusual expense (income)--------
Other operating expenses, total--------
Operating income2122
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets000--
Other--------
Income before tax2122
Income after tax2122
Income tax, total0000
Net income212-1
Total adjustments to net income--------
Net income before extra. items2122
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2122
Inc. avail. to common incl. extra. items212-1
Diluted net income212-1
Dilution adjustment--00--
Diluted weighted average shares12121211
Diluted EPS excluding extraordinary itemsvalue per share0.150.100.210.17
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.150.100.210.17